메뉴 건너뛰기




Volumn 338, Issue 7686, 2009, Pages 81-83

Minimal access surgery compared with medical management for chronic gastro-oesophageal reflux disease: UK collaborative randomised trial

(92)  Grant, Adrian M a   Wileman, Samantha M a   Ramsay, Craig R a   Mowat, N Ashley b   Krukowski, Zygmunt H b   Heading, Robert C c   Thursz, Mark R d   Campbell, Marion K a   Mowat, A b   Krukowski, Z b   El Omar, E b   Phull, P b   Sinclair, T b   Swan, L b   Clements, B e   Collins, J e   Kennedy, A e   Lawther, H e   Bennett, D f   Davies, N f   more..


Author keywords

[No Author keywords available]

Indexed keywords

LANSOPRAZOLE; OMEPRAZOLE;

EID: 61849145327     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.a2664     Document Type: Article
Times cited : (5)

References (14)
  • 1
    • 0028117038 scopus 로고
    • Epidemiology of abdominal symptoms in a random population: Prevalence, incidence, and natural history
    • Kay L, Jorgensen T, Hougaard Jensen K. Epidemiology of abdominal symptoms in a random population: prevalence, incidence, and natural history. Eur J Epidemiol 1994;10:559-66.
    • (1994) Eur J Epidemiol , vol.10 , pp. 559-566
    • Kay, L.1    Jorgensen, T.2    Hougaard Jensen, K.3
  • 3
    • 0034038649 scopus 로고    scopus 로고
    • Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors
    • Laine L, Ahnen D, McClain C, Solcia E, Walsh JH. Potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors. Aliment Pharmacol Ther 2000;14:651-68.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 651-668
    • Laine, L.1    Ahnen, D.2    McClain, C.3    Solcia, E.4    Walsh, J.H.5
  • 5
    • 0032583868 scopus 로고    scopus 로고
    • Understanding controlled trials: What is a patient preference trial?
    • Torgerson D, Sibbald B. Understanding controlled trials: What is a patient preference trial? BMJ 1998;316:360.
    • (1998) BMJ , vol.316 , pp. 360
    • Torgerson, D.1    Sibbald, B.2
  • 6
    • 0035835413 scopus 로고    scopus 로고
    • Management of gastro-oesophageal reflux disease in general practice
    • Dent J, Jones R, Kahrilas PJ, Talley NJ. Management of gastro-oesophageal reflux disease in general practice. BMJ 2001;322:344-7.
    • (2001) BMJ , vol.322 , pp. 344-347
    • Dent, J.1    Jones, R.2    Kahrilas, P.J.3    Talley, N.J.4
  • 7
    • 33846149982 scopus 로고    scopus 로고
    • The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: The Reflux questionnaire
    • Macran S, Wileman S, Barton G, Russell I. The development of a new measure of quality of life in the management of gastro-oesophageal reflux disease: the Reflux questionnaire. Qual Life Res 2007;16:331-43.
    • (2007) Qual Life Res , vol.16 , pp. 331-343
    • Macran, S.1    Wileman, S.2    Barton, G.3    Russell, I.4
  • 8
    • 0034517882 scopus 로고    scopus 로고
    • Symptomatic outcome following laparoscopic anterior partial fundoplication: Follow-up of a series of 200 patients
    • Ross S, Jabbar A, Ramsay CR, Watson AJM, Grant AM, Krukowski ZH. Symptomatic outcome following laparoscopic anterior partial fundoplication: follow-up of a series of 200 patients. J R Coll Surg Edinb 2000;45:363-5.
    • (2000) J R Coll Surg Edinb , vol.45 , pp. 363-365
    • Ross, S.1    Jabbar, A.2    Ramsay, C.R.3    Watson, A.J.M.4    Grant, A.M.5    Krukowski, Z.H.6
  • 9
    • 0035832264 scopus 로고    scopus 로고
    • Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: Follow-up of a randomized controlled trial
    • Spechler JS, Lee E, Ahnen D, Goyal RK, Hirano I, Ramirez F, et al. Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA 2001;285:2331-8.
    • (2001) JAMA , vol.285 , pp. 2331-2338
    • Spechler, J.S.1    Lee, E.2    Ahnen, D.3    Goyal, R.K.4    Hirano, I.5    Ramirez, F.6
  • 10
    • 0034734141 scopus 로고    scopus 로고
    • Estimating treatment effects in randomised clinical trials in the presence of non-compliance
    • Nagelkerke N, Fidler V, Bersen R, Borgdorff M. Estimating treatment effects in randomised clinical trials in the presence of non-compliance. Stat Med 2000;19:1849-64.
    • (2000) Stat Med , vol.19 , pp. 1849-1864
    • Nagelkerke, N.1    Fidler, V.2    Bersen, R.3    Borgdorff, M.4
  • 11
    • 24944468294 scopus 로고    scopus 로고
    • Uses and limitations of randomization-based efficacy estimators
    • White IR. Uses and limitations of randomization-based efficacy estimators. Stat Methods Med Res 2005;14:327-47.
    • (2005) Stat Methods Med Res , vol.14 , pp. 327-347
    • White, I.R.1
  • 12
    • 34147155232 scopus 로고    scopus 로고
    • Levels of evidence for techniques in antireflux surgery
    • Neufeld M, Graham A. Levels of evidence for techniques in antireflux surgery. Dis Esophagus 2007;20:161-7.
    • (2007) Dis Esophagus , vol.20 , pp. 161-167
    • Neufeld, M.1    Graham, A.2
  • 13
    • 20844458572 scopus 로고    scopus 로고
    • Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux
    • Mahon D, Rhodes M, Decadt B, Hindmarsh A, Lowndes R, Beckingham I, et al. Randomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal reflux. Br J Surg 2005;92:695-9.
    • (2005) Br J Surg , vol.92 , pp. 695-699
    • Mahon, D.1    Rhodes, M.2    Decadt, B.3    Hindmarsh, A.4    Lowndes, R.5    Beckingham, I.6
  • 14
    • 33845623820 scopus 로고    scopus 로고
    • A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-up
    • Anvari M, Allen C, Marshall J, Armstrong D, Goeree R, Ungar W, et al. A randomized controlled trial of laparoscopic Nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: one-year follow-up. Surg Innov 2006;13:238-49.
    • (2006) Surg Innov , vol.13 , pp. 238-249
    • Anvari, M.1    Allen, C.2    Marshall, J.3    Armstrong, D.4    Goeree, R.5    Ungar, W.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.